- Home
- BLMZ vs KZIA Comparison
BLMZ vs KZIA Comparison
Compare BLMZ & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLMZ
- KZIA
- Stock Information
- Founded
- BLMZ 2017
- KZIA 1994
- Country
- BLMZ Japan
- KZIA Australia
- Employees
- BLMZ N/A
- KZIA N/A
- Industry
- BLMZ
- KZIA Biotechnology: Pharmaceutical Preparations
- Sector
- BLMZ
- KZIA Health Care
- Exchange
- BLMZ NYSE
- KZIA Nasdaq
- Market Cap
- BLMZ 5.3M
- KZIA 860.8K
- IPO Year
- BLMZ 2024
- KZIA 1999
- Fundamental
- Price
- BLMZ $0.15
- KZIA $3.51
- Analyst Decision
- BLMZ
- KZIA Strong Buy
- Analyst Count
- BLMZ 0
- KZIA 2
- Target Price
- BLMZ N/A
- KZIA $57.50
- AVG Volume (30 Days)
- BLMZ 13.1M
- KZIA 44.4K
- Earning Date
- BLMZ 02-15-2025
- KZIA 05-16-2025
- Dividend Yield
- BLMZ N/A
- KZIA N/A
- EPS Growth
- BLMZ N/A
- KZIA N/A
- EPS
- BLMZ N/A
- KZIA N/A
- Revenue
- BLMZ $1,535,822.00
- KZIA $1,655,324.00
- Revenue This Year
- BLMZ N/A
- KZIA N/A
- Revenue Next Year
- BLMZ N/A
- KZIA N/A
- P/E Ratio
- BLMZ N/A
- KZIA N/A
- Revenue Growth
- BLMZ 71.48
- KZIA 248000.00
- 52 Week Low
- BLMZ $0.11
- KZIA $2.86
- 52 Week High
- BLMZ $4.30
- KZIA $79.00
- Technical
- Relative Strength Index (RSI)
- BLMZ N/A
- KZIA 39.60
- Support Level
- BLMZ N/A
- KZIA $3.05
- Resistance Level
- BLMZ N/A
- KZIA $3.50
- Average True Range (ATR)
- BLMZ 0.00
- KZIA 0.42
- MACD
- BLMZ 0.00
- KZIA 0.01
- Stochastic Oscillator
- BLMZ 0.00
- KZIA 14.84
About BLMZ BLOOMZ INC
BloomZ Inc operates as an audio-producing and voice actor managing company. The company provides audio production services and voice-acting educational services in Japan. The business lines of the company are the audio production business, the VTuber management business, and the voice actor workshop business. The audio production comprises producing audios for animations and video games using dubbing, BGM producing, and mixing techniques; the Vtuber management business creates motion-capture technology for streamers to provide the voice to stream real-time videos featuring human facial expressions and gestures; and the voice actor workshop provides practical voice acting services.
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.